Vascular endothelial growth factor (VEGF), one of the most potent factors mediating tumor angiogenesis, was markedly elevated in the majority of patients with HCC after local therapy and was considered to be one of the most important factors of tumor residue and recurrence [9, 10]. This evidence concerns the gene VEGFA and hepatocellular carcinoma.